TruaceTracing the truth around AITuesday, September 15, 2026
The Index

What the evidence says.What the public feels.

Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.

1,419 results
Show filters and sorting

AI gains · 788

71
GainScience· Stable· Evidence: High (5 sources)

Combining machine learning with multiscale modeling creates robust predictive models that integrate underlying physics to manage ill-posed problems and can provide insights into disease mechanisms and treatment strategies.

Published in November 2019, this perspective review argues that breakthrough data collection in biology and medicine requires new analysis strategies. The authors contend that machine learning and multiscale modeling are complementary and demonstrate how their integration can produce physics-aware predictive models that handle massive, heterogeneous datasets.

Impact 30%49
Evidence 25%100
Scale 20%35
Confidence 15%100
Recency 10%88

Updated Jul 13, 2026 · TRV-2026-0204

71
GainScience· Rising· Evidence: High (5 sources)

AlphaFold provides a computational method that regularly predicts protein three-dimensional structures with atomic accuracy from amino acid sequence alone, even without homologous structures.

On July 15, 2021, Nature published the AlphaFold study describing a redesigned neural network that predicts the three-dimensional structure a protein will adopt based solely on its amino acid sequence. The authors reported validation in CASP14, where the model regularly achieved atomic accuracy even when no homologous structure was available and performed competitively with experimental structures.

Impact 30%49
Evidence 25%100
Scale 20%35
Confidence 15%100
Recency 10%88

Updated Jul 13, 2026 · TRV-2026-0203

71
GainCrime· Stable· Evidence: High (4 sources)

XAI-driven data mining applied to IoT ecosystems can detect anomalies and support automated security decisions through transparent and interpretable reasoning for smart city infrastructure.

Published February 20, 2026, this peer-reviewed survey in Cognitive Computation reviews XAI-driven data mining for self-defending IoT systems. It describes how IoT expansion in smart cities, healthcare, and industrial automation creates need for real-time, scalable security, and how XAI methods aim to detect anomalies and support automated decisions with transparent reasoning.

Impact 30%49
Evidence 25%100
Scale 20%35
Confidence 15%100
Recency 10%88

Updated Jul 13, 2026 · TRV-2026-0201

71
GainEducation· Stable· Evidence: High (5 sources)

Chinese EFL students who received robot-assisted language instruction showed significantly higher classroom engagement and willingness to attend classes after a four-month intervention compared to controls.

In a four-month randomized trial reported April 30, 2026, 155 Chinese EFL students were split into a control group of 80 and an experimental group of 75 that received robot-assisted language instruction. Questionnaires at the start and end measured classroom engagement and willingness to attend classes.

Impact 30%49
Evidence 25%100
Scale 20%35
Confidence 15%100
Recency 10%88

Updated Jul 13, 2026 · TRV-2026-0200

AI problems · 631

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

The same canine lymphoma cytology AI performed less favorably on B-cell versus T-cell classification, prompting concern that allowing outputs to influence reports without pathologist review and without assessing whether the specimen supports the claim could lead to unsupported clinical claims.

On August 24, 2026, a commentary in the Journal of Veterinary Diagnostic Investigation argued that veterinary diagnostic laboratories should decide what AI outputs are permitted to do in service, not just how accurate models are. It defines service entry as the moment an output can influence triage, interpretation, draft reports, or result release, and proposes a standard operating procedure covering intended use, reviewer and signer roles, disclosure, input compatibility, refusal conditions, pathologist override, QC monitoring, and stop rules.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 25, 2026 · TRV-2026-0877

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

AI use in mental health care is limited by data bias, limited external validity, methodological heterogeneity, insufficient transparency, and weaker evidence for sustained therapeutic interventions.

This umbrella review synthesized 27 systematic reviews with over 14 million participants to examine AI applications in mental health care between 2021 and 2025. It found AI improved early detection and risk stratification for depression, anxiety, stress, PTSD and suicidal ideation, and that chatbots and mobile platforms expanded access and engagement.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 25, 2026 · TRV-2026-0874

68
ProblemMedia & Arts· Stable· Evidence: Moderate (1 source)

Current newsroom AI assessments focus narrowly on technical accuracy or efficiency and struggle to capture broader organizational and ethical implications for trust, governance, and human collaboration.

As of November 2025, this peer-reviewed review examines agentic AI in newsrooms that can autonomously plan, decide, and generate content. Analyzing 46 sources from 2015-2025, it finds current evaluations emphasize technical accuracy and efficiency while neglecting trust, governance, and collaboration.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 24, 2026 · TRV-2026-0868

68
ProblemHealth· Stable· Evidence: Moderate (1 source)

In the matched Stage II-III cohort, patients with low lymph node ratio showed potential harm from adjuvant chemotherapy, indicating heterogeneous treatment effects and risk of overtreatment.

Researchers used a Causal Forest causal machine learning model on a retrospective cohort of gastric cancer patients treated between 2007 and 2017 to estimate who benefits from adjuvant chemotherapy. The model identified lymph node ratio as the most dominant predictor of benefit, with a significant interaction at a 0.25 threshold in a propensity-matched Stage II-III cohort.

Impact 30%49
Evidence 25%95
Scale 20%35
Confidence 15%87
Recency 10%96

Updated Aug 24, 2026 · TRV-2026-0866

Recomputed live from the record · Sep 16, 2026, 1:52 AM